Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

Completed

Conditions studied: Hepatitis B

In brief

We propose a largely retrospective study with short-term prospective follow-up in a subgroup of patients who have not yet been treated with 48 weeks of entecavir following partial response to adefovir. The aim of the study is to describe sequential virologic response to adefovir and entecavir.

Key facts

Study ID

NCT00704106

Run by

Pacific Health Foundation

People needed

60

Starts

2008-05-01

Expected to finish

2011-10-01

Last updated by the study team

2022-11-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Stanford University Medical Center — Palo Alto, California, United States
• San Jose Gastroenterology — San Jose, California, United States
• San Jose Gastroenterology — San Jose, California, United States
• Asian Village Medical Clinic — Chicago, Illinois, United States
• Houston Gastroenterology Clinic — Houston, Texas, United States
• Digestive Health Associates of Texas — Plano, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.